Sonoma Pharmaceuticals Inc (SNOA) — Cash Flow Quality Index
Sonoma Pharmaceuticals Inc (SNOA) has a Cash Flow Quality Index of -2.30x as of June 2020. Operating cash flow of $-2.28 Million is below net income of $993.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore SNOA long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sonoma Pharmaceuticals Inc Cash Flow Quality Index (2014–2017)
Historical Cash Flow Quality Index for Sonoma Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SNOA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sonoma Pharmaceuticals Inc (2014–2017)
Year-by-year earnings quality comparison for Sonoma Pharmaceuticals Inc. For live market cap and the full company financial profile, see SNOA company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2017 | -0.88x | $-8.17 Million | $9.27 Million | ▲ +32.7% |
| 2014 | -1.31x | $-4.89 Million | $3.73 Million | — |